Regulation of G0-G1 Transition in Hepatocytes

肝细胞 G0-G1 转变的调节

基本信息

  • 批准号:
    7267960
  • 负责人:
  • 金额:
    $ 23.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-07-10 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): During liver regeneration, quiescent hepatocytes reenter the cell cycle, proliferate and repopulate the diseased liver. This process is observed in many forms of acute liver injury specifically those caused by viruses, toxins and trauma. Therefore, prognosis in acute liver failure often depends on the ability of proliferation to outlast liver cell necrosis. The long-term objective of the studies outlined here is to use recent knowledge of events that regulate exit from quiescence to identify liver specific targets in the initiation of liver regeneration. The first aim of the study is to evaluate for novel cyclin dependent kinase activities that regulate the transition from quiescence to active cell cycling. We believe that cyclin dependent kinase activities that precede the canonical Gi cyclins are important in transiting from G0 to GI during the regenerative process. The second aim of the study is to design a siRNA based screen that targets genes up regulated in the priming phase of liver regeneration. The goal is to identify genes whose products are necessary for cycle progression. Our hope is to identify physiologically relevant molecules that can be therapeutic targets for enhancement of liver proliferation. A cell based assay using H35 rat liver cell line, which can undergo the transition from quiescence to cell cycle reentry, will be used for both lines of inquiry.
描述(申请人提供):在肝脏再生过程中,静止的肝细胞重新进入细胞周期,增殖并重新填充病变的肝脏。在许多形式的急性肝损伤中都可以观察到这一过程,特别是那些由病毒、毒素和创伤引起的急性肝损伤。因此,急性肝功能衰竭的预后往往取决于肝细胞的增殖能力超过肝细胞坏死的时间。本文概述的研究的长期目标是利用调节从静止状态退出的事件的最新知识来确定启动肝脏再生的肝脏特异性靶点。这项研究的第一个目的是评估调节细胞周期从静止到活跃的转变的新的细胞周期蛋白依赖性激酶活性。我们认为,在再生过程中,典型的GI细胞周期蛋白之前的细胞周期蛋白依赖的激酶活性在从G0到GI的转变过程中是重要的。这项研究的第二个目的是设计一种基于siRNA的筛选,针对在肝脏再生的启动阶段上调的基因。目标是确定其产物对周期进程是必要的基因。我们希望找出与生理相关的分子,作为促进肝脏增殖的治疗靶点。使用H35大鼠肝细胞系的基于细胞的分析将用于这两种研究路线,该细胞系可以经历从静止到细胞周期重入的转变。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Chinweike Ukomadu其他文献

Chinweike Ukomadu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Chinweike Ukomadu', 18)}}的其他基金

Regulation of G0-G1 Transition in Hepatocytes
肝细胞 G0-G1 转变的调节
  • 批准号:
    7142463
  • 财政年份:
    2006
  • 资助金额:
    $ 23.3万
  • 项目类别:
Cell cycle block by HMG co-A reductase inhibitors
HMG co-A 还原酶抑制剂阻断细胞周期
  • 批准号:
    6902585
  • 财政年份:
    2003
  • 资助金额:
    $ 23.3万
  • 项目类别:
Cell cycle block by HMG co-A reductase inhibitors
HMG co-A 还原酶抑制剂阻断细胞周期
  • 批准号:
    7252472
  • 财政年份:
    2003
  • 资助金额:
    $ 23.3万
  • 项目类别:
Cell cycle block by HMG co-A reductase inhibitors
HMG co-A 还原酶抑制剂阻断细胞周期
  • 批准号:
    6801016
  • 财政年份:
    2003
  • 资助金额:
    $ 23.3万
  • 项目类别:
Cell cycle block by HMG co-A reductase inhibitors
HMG co-A 还原酶抑制剂阻断细胞周期
  • 批准号:
    6685365
  • 财政年份:
    2003
  • 资助金额:
    $ 23.3万
  • 项目类别:
Cell cycle block by HMG co-A reductase inhibitors
HMG co-A 还原酶抑制剂阻断细胞周期
  • 批准号:
    7073413
  • 财政年份:
    2003
  • 资助金额:
    $ 23.3万
  • 项目类别:

相似海外基金

Senescent hepatocytes mediate reprogramming of immune cells in acute liver failure
衰老肝细胞介导急性肝衰竭中免疫细胞的重编程
  • 批准号:
    10679938
  • 财政年份:
    2023
  • 资助金额:
    $ 23.3万
  • 项目类别:
Hepatocytes Encapsulated with mesenchymal stromal cells in alginate microbeads for the treatment of acute Liver failure in Paediatric patients (HELP)
将间充质基质细胞封装在藻酸盐微珠中的肝细胞用于治疗儿科患者的急性肝衰竭(HELP)
  • 批准号:
    MR/V038583/1
  • 财政年份:
    2022
  • 资助金额:
    $ 23.3万
  • 项目类别:
    Research Grant
Development of the innovative treatment using self iPS cell for acute liver failure
开发利用自身 iPS 细胞治疗急性肝衰竭的创新疗法
  • 批准号:
    21K08685
  • 财政年份:
    2021
  • 资助金额:
    $ 23.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
  • 批准号:
    10421290
  • 财政年份:
    2021
  • 资助金额:
    $ 23.3万
  • 项目类别:
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
  • 批准号:
    10180251
  • 财政年份:
    2021
  • 资助金额:
    $ 23.3万
  • 项目类别:
Therapeutic effect of plasmacytoid dendritic cells transplantation for acute liver failure
浆细胞样树突状细胞移植治疗急性肝衰竭的疗效
  • 批准号:
    20K21607
  • 财政年份:
    2020
  • 资助金额:
    $ 23.3万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Macrophage Therapy for Acute Liver Failure
巨噬细胞治疗急性肝衰竭
  • 批准号:
    MR/T044802/1
  • 财政年份:
    2020
  • 资助金额:
    $ 23.3万
  • 项目类别:
    Research Grant
Investigation of an optimal environment for the proliferation of mature hepatocytes toward the rescue of acute liver failure patients
研究成熟肝细胞增殖的最佳环境以挽救急性肝衰竭患者
  • 批准号:
    19K08475
  • 财政年份:
    2019
  • 资助金额:
    $ 23.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure (PALF) TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)
小儿急性肝衰竭 (PALF) 免疫介导病理生理学治疗 (TRIUMPH)
  • 批准号:
    9789253
  • 财政年份:
    2018
  • 资助金额:
    $ 23.3万
  • 项目类别:
Cryopreservation of hiPS-derivd hepatic progenitor cells and application to acute liver failure treatment
hiPS源性肝祖细胞的冷冻保存及其在急性肝衰竭治疗中的应用
  • 批准号:
    18K08662
  • 财政年份:
    2018
  • 资助金额:
    $ 23.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了